PBCLN-014
N/A
Report date: 2024/08/20 20:00:16
Base Information
Drug NamePBCLN-014
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesProlacta Bioscience Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesProlacta Bioscience Inc
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A